RedHill Biopharma (RDHL) EBITDA Margin Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) EBITDA Margin Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | RedHill Biopharma | 142.34 Mn | 142.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 258,619.00 |
| Mar 31, 2023 | -121,680.00 |
| Dec 31, 2022 | -130,975.00 |
| Sep 30, 2022 | -71,354.00 |
| Jun 30, 2022 | -275,318.00 |
| Sep 30, 2020 | -32.91 Mn |
| Jun 30, 2020 | -65.95 Mn |
| Dec 31, 2019 | -53.21 Mn |
| Sep 30, 2019 | 70,254.00 |
| Jun 30, 2019 | -11.23 Mn |
| Mar 31, 2019 | 48,340.00 |
| Dec 31, 2018 | 73,866.00 |
| Sep 30, 2018 | 9.04 Mn |
| Jun 30, 2018 | -6.24 Mn |
| Dec 31, 2017 | 8.45 Mn |
| Sep 30, 2017 | 6.65 Mn |
| Jun 30, 2017 | -4.27 Mn |